Figure 1. Failure mode of anticoagulation strategy. Types, numbers, and frequencies of medication problems among patients prescribed DOACs and VKAs. DOACs: direct-acting oral anticoagulants; VKAs: vitamin K antagonists.
| Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc |
| Journal website https://www.cardiologyres.org |
Short Communication
Volume 12, Number 4, August 2021, pages 265-268
Prevalence and Risk Factors for Preprocedural Medication Errors in Patients With Atrial Fibrillation and Atrial Flutter
Figures
Table
| Characteristics | All procedures (N = 1,248) | Procedures with medication problems (N = 140) | Procedures without medication problems (N = 1,108) | P value |
|---|---|---|---|---|
| Unless otherwise specified, parameters are expressed as mean ± standard error. The listed P values relate to the comparison of procedures with medication problems versus procedures without medication problems. BMI: body mass index; CHA2DS2-VASc: congestive heart failure, hypertension, age, diabetes mellitus, stroke/systemic embolism, vascular disease; DCCV: direct current cardioversion; PVI: pulmonary vein isolation. | ||||
| Age | 68 ± 11 | 69 ± 11 | 68 ± 11 | 0.439 |
| Gender | ||||
| Women, N (%) | 412 (33) | 45 (32.1) | 367 (33.1) | 0.816 |
| Race/ethnicity, N (%) | 0.291 | |||
| Asian | 18 (1.4) | 4 (2.9) | 14 (1.3) | |
| Black | 70 (5.6) | 9 (6.4) | 61 (5.5) | |
| Hispanic | 18 (1.4) | 0 (0) | 18 (1.6) | |
| White | 972 (77.9) | 106 (75.7) | 866 (78.2) | |
| Not reported | 170 (13.6) | 21 (15.0) | 149 (13.5) | |
| Not primarily English-speaking, N (%) | 82 (6.6) | 12 (8.6) | 70 (6.3) | 0.311 |
| Insurance type, N (%) | 0.457 | |||
| Commercial | 709 (56.8) | 74 (52.9) | 635 (57.3) | |
| Medicare | 515 (41.3) | 64 (45.7) | 451 (40.7) | |
| Safety Net | 24 (1.9) | 2 (1.4) | 22 (1.9) | |
| CHA2DS2-VASc | 3.0 ± 1.9 | 3.1 ± 1.8 | 3.0 ± 1.9 | 0.575 |
| BMI | 30.2 ± 6.7 | 30.2 ± 6.3 | 30.3 ± 6.8 | 0.914 |
| Creatinine | 1.2 ± 0.8 | 1.4 ± 1.2 | 1.2 ± 0.8 | 0.098 |
| Warfarin use, N (%) | 193 (15.5) | 43 (30.7) | 150 (13.5) | < 0.0001 |
| Median income | $94,622 ± $33,962 | $93,884 ± $35,348 | $94,717 ± $33,796 | 0.785 |
| Poverty rate | 9.7±7.5% | 10.4±8.2% | 9.6±7.4% | 0.200 |
| Procedures, N (%) | 0.002 | |||
| DCCV | 756 (60.6) | 92 (65.1) | 664 (59.9) | |
| PVI | 307 (24.6) | 41 (29.3) | 266 (24) | |
| Atrial flutter ablation | 185 (14.8) | 7 (5) | 178 (16.1) | |